Teshima T. The primacy of IL-6 in IPS?. Blood. 2015 Apr 9;125(15):2320-2.
Ogata M, Fukuda T, Teshima T. Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.Bone Marrow Transplant. 2015 Aug;50(8):1030-6.
英文原著
Uryu H, Hashimoto D, Kato K, Hayase E, Matsuoka S, Ogasawara R, Takahashi S, Maeda Y, Iwasaki H, Miyamoto T, Saijo S, Iwakura Y, Hill GR, Akashi K, Teshima T.:α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice.:Blood. 2015 May:7;125(19):3014-23.
Sugita J, Kawashima N, Fujisaki T, Kakihana K, Ota S, Matsuo K, Miyamoto T, Akashi K, Taniguchi S, Harada M, Teshima T; Japan Study Group for Cell Therapy and Transplantation..HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.:Biol Blood Marrow Transplant. 2015 Sep;21(9):1646-52.
Shiratori S, Ohigashi H, Ito S, Kudo K, Adachi M, Minamimoto T, Kato J, Osai Y, Tsutsumi Y, Teshima T.:Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia/lymphoma:Hematol Oncol. 2015 Jul 14.
Shiratori S, Fujimoto K, Nishimura M, Hatanaka KC, Kosugi-Kanaya M, Okada K, Sugita J, Shigematsu A, Hashimoto D, Endo T, Kondo T, Abe R, Hashino S, Matsuno Y, Shimizu H, Teshima T.:Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.:Hematol Oncol. 2016 Mar;34(1):9-16.
Shiratori S, Kosugi-Kanaya M, Shigematsu A, Kobayashi H, Yamamoto S, Kobayashi N, Iwasaki H, Mori A, Kunieda Y, Yutaka T, Kurosawa M, Kakinoki Y, Endo T, Kondo T, Hashino S, Teshima T; North Japan Hematology Study Group (NJHSG)..:Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.:Leuk Lymphoma. 2015;56(9):2592-7.
Nishida M, Shigematsu A, Sato M, Kudo Y, Omotehara S, Horie T, Iwai T, Endo T, Iguchi A, Shibuya H, Hatanaka K, Shimizu C, Teshima T.:Ultrasonographic evaluation of gastrointestinal graft-versus-host disease after hematopoietic stem cell transplantation.:Clin Transplant. 2015 Aug;29(8):697-704.
Hayase E, Kurosawa M, Suzuki H, Kasahara K, Yamakawa T, Yonezumi M, Suzuki S, Teshima T.:Primary Bone Lymphoma: A Clinical Analysis of 17 Patients in a Single Institution.:Acta Haematol. 2015;134(2):80-5.
Takemura R, Takaki H, Okada S, Shime H, Akazawa T, Oshiumi H, Matsumoto M, Teshima T, Seya T.:PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.:Cancer Immunol Res. 2015 Aug;3(8):902-14.
Takahashi S, Kasamatsu J, Azuma M, Matsumoto M, Morii-Sakai A, Imamura M, Teshima T, Takahashi A, Hirohashi Y, Torigoe T, Sato N, Seya T.:PolyI:C and mouse survivin artificially embedding human 2B peptide induce a CD4+ T cell response to autologous survivin in HLA-A*2402 transgenic mice.:Immunobiology. 2015 Jan;220(1):74-82.
Onozawa M, Goldberg L, Aplan PD.:Landscape of insertion polymorphisms in the human genome.:Genome Biol Evol. 2015 Mar 4;7(4):960-8.
Shibayama Y, Kondo T, Ohya H, Fujisawa S, Teshima T, Iseki K.:Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.:Oncol Rep. 2015 May;33(5):2176-82.
Tsutsumi Y, Shimono J, Ohhigashi H, Ito S, Shiratori S, Teshima T.:Analysis of the influence of dabigatran on coagulation factors and inhibitors.:Int J Lab Hematol. 2015 Apr;37(2):225-30.
Takahata M, Hashino S, Nishio M, Sugita J, Shigematsu A, Onozawa M, Fujimoto K, Endo T, Kondo T, Tanaka J, Imamura M, Teshima T.:Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.:Transpl Infect Dis. 2015 Dec;17(6):810-5
CSuehiro Y, Hasegawa A, Iino T, Sasada A, Watanabe N, Matsuoka M, Takamori A, Tanosaki R, Utsunomiya A, Choi I, Fukuda T, Miura O, Takaishi S, Teshima T, Akashi K, Kannagi M, Uike N, Okamura J.:linical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.:Br J Haematol. 2015 May;169(3):356-67.
Eriguchi Y, Nakamura K, Hashimoto D, Shimoda S, Shimono N, Akashi K, Ayabe T, Teshima T.:Decreased secretion of Paneth cell α-defensins in graft-versus-host disease.:Transpl Infect Dis. 2015 Oct;17(5):702-6.
Shima T, Iwasaki H, Yamauchi T, Kadowaki M, Kiyosuke M, Mochimaru T, Takenaka K, Miyamoto T, Akashi K, Teshima T.:Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at -80 °C.:Bone Marrow Transplant. 2015 Sep;50(9):1195-200.
Yutaka T, Ito S, Ohigashi H, Naohiro M, Shimono J, Souichi S, Teshima T.:Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma.:Leuk Lymphoma. 2015;56(11):3216-8.
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M; GVHD working group of the Japan Society of Hematopoietic Cell Transplantation..:Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.:Bone Marrow Transplant. 2015 Apr;50(4):559-65.
Takashima S, Miyamoto T, Kamimura T, Yoshimoto G, Yoshida S, Henzan H, Takase K, Kato K, Ito Y, Ohno Y, Nagafuji K, Eto T, Techima T, Akashi K.:Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome‑positive acute lymphoblastic leukemia.:Int J Hematol. 2015 Dec;102(6):689-96.
Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ; Graft-vs-Host Disease Working Committee of the CIBMTR..:Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.:Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74
Schmeel LC, Schmeel FC, Kim Y, Blaum-Feder S, Endo T, Schmidt-Wolf IG.:In vitro efficacy of cinnarizine against lymphoma and multiple myeloma.:Anticancer Res. 2015 Feb;35(2):835-41.
Tan EJ, Kahata K, Idås O, Thuault S, Heldin CH, Moustakas A.:The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition.Nucleic Acids Res. 2015 Jan;43(1):162-78.
Suenaga F, Ueha S, Abe J, Kosugi-Kanaya M, Wang Y, Yokoyama A, Shono Y, Shand FH, Morishita Y, Kunisawa J, Sato S, Kiyono H, Matsushima K.:Loss of lymph node fibroblastic reticular cells and high endothelial cells is associated with humoral immunodeficiency in mouse graft-versus-host disease.:J Immunol. 2015 Jan 1;194(1):398-406.
Aoki T, Suzuki R, Kuwatsuka Y, Kako S, Fujimoto K, Taguchi J, Kondo T, Ohata K, Ito T, Kamoda Y, Fukuda T, Ichinohe T, Takeuchi K, Izutsu K, Suzumiya J.:Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.:Blood. 2015 Jun 4;125(23):3559-62.
Moskalenko M, Pan M, Fu Y, de Moll EH, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Bernardo S, Sikora AG, Wolchok J, Bhardwaj N, Merad M, Saenger Y.:Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.:Cancer Immunol Res. 2015 Mar;3(3):296-304.
Aoki J, Kanamori H, Tanaka M, Yamasaki S, Fukuda T, Ogawa H, Iwato K, Ohashi K, Okumura H, Onizuka M, Maesako Y, Teshima T, Kobayashi N, Morishima Y, Hirokawa M, Atsuta Y, Yano S, Takami A.:Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia.:Am J Hematol. 2016 Mar;91(3):302-7.
Schmeel LC, Schmeel FC, Kim Y, Blaum-Feder S, Endo T, Schmidt-Wolf IG.:Flunarizine exhibits in vitro efficacy against lymphoma and multiple myeloma cells.:Anticancer Res. 2015 Mar;35(3):1369-76.
Cui Y, Onozawa M, Garber HR, Samsel L, Wang Z, McCoy JP, Burkett S, Wu X, Aplan PD, Mackall CL.:Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL.:Blood. 2015 May 7;125(19):2958-67.
Shichino S, Abe J, Ueha S, Otsuji M, Tsukui T, Kosugi-Kanaya M, Shand FH, Hashimoto S, Suzuki HI, Morikawa T, Inagaki Y, Matsushima K.:Reduced supply of monocyte-derived macrophages leads to a transition from nodular to diffuse lesions and tissue cell activation in silica-induced pulmonary fibrosis in mice.:Am J Pathol. 2015 Nov;185(11):2923-38.
Inamoto Y, Flowers ME, Wang T, Urbano-Ispizua A, Hemmer MT, Cutler CS, Couriel DR, Alousi AM, Antin JH, Gale RP, Gupta V, Hamilton BK, Kharfan-Dabaja MA, Marks DI, Ringdén OT, Socié G, Solh MM, Akpek G, Cairo MS, Chao NJ, Hayashi RJ, Nishihori T, Reshef R, Saad A, Shah A, Teshima T, Tallman MS, Wirk B, Spellman SR, Arora M, Martin PJ.:Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.:Biol Blood Marrow Transplant. 2015 Oct;21(10):1776-82.
英文症例報告
Ishio T, Endo T, Okada K, Shigematsu A, Hashino S, Teshima T.:Human Herpesvirus-6 Pneumonitis around the Engraftment of Cord Blood Transplantation following Foscarnet Prophylaxis in a Patient with Acute Leukemia.:Case Rep Hematol. 2015;2015:949265.
Imafuku K, Nomura Y, Nakayama C, Abe R, Endo T, Shimizu H.:Erythema annulare centrifugum-like mycosis fungoides after unrelated bone marrow transplantation.:Br J Haematol. 2015 Jul;170(2):140.
Miyauchi T, Abe R, Morita Y, Adachi M, Shiba K, Hamade Y, Saito N, Nishimura M, Ibata M, Okada K, Shigematsu A, Endo T, Kawai K, Teshima T, Shimizu H.:CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?:Acta Derm Venereol. 2015 Nov;95(8):1024-5.
